Galectin Therapeutics Inc. (GALT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 265.84M |
| Enterprise Value | 381.87M |
| P/E Ratio | -7.06 |
| PEG Ratio | -0.11 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -1.45 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -16.7 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.67 |
| Return On Equity | 0.21 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -23.45M |
| Net Income | -30.84M |
| Diluted EPS | -0.48 |
| Total Cash | 14.11M |
| Total Cash/Share | 0.21 |
| Total Debt | 135.72M |
| Total Debt/Equity | -1.04 |
| Current Ratio | 2.15 |
| Book Value Per Share | -1.98 |
| 52-Week Change | 15.92 |
| 52-Week High | 7.13 |
| 52-Week Low | 2.03 |
| Moving Average 50 Days | 2.39 |
| Moving Average 200 Days | 3.75 |
| Average Volume | 319,596 |
| Shares Outstanding | 65.86M |
| % Held by Institutions | 21.71 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0 |
| Last Split Factor | 1:6 |
| Last Split Date | March 23, 2012 |